Provided by Tiger Fintech (Singapore) Pte. Ltd.

DarioHealth

0.7341
+0.03034.31%
Volume:136.72K
Turnover:101.95K
Market Cap:30.51M
PE:-1.20
High:0.7600
Open:0.7000
Low:0.7000
Close:0.7038
Loading ...

Company Profile

Company Name:
DarioHealth
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
199
Office Location:
322 W 57th Street,suite 33 B,New York,New York,United States
Zip Code:
10019
Fax:
- -
Introduction:
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Directors

Name
Position
Erez Raphael
Chief Executive Officer and Director
Yoav Shaked
Chairman of the Board
Adam Stern
Director
Dennis M. McGrath
Director
Dennis Matheis
Director
Hila Karah
Director
Jon Kaplan
Director

Shareholders

Name
Position
Erez Raphael
Chief Executive Officer and Director
Zvi Ben David
Chief Financial Officer, Treasurer and Secretary
Steven Nelson
Chief Commercial Officer